Blog

Clinical Trials Bulgaria: Growing Team of +70 Clinical Investigators in Eastern Europe

At Convex private clinical research center with phase I unit, […]

Convex to Participate in CPHI Europe 2025 in Frankfurt

Convex, a leading Contract Research site in Eastern Europe specializing […]

Convex CRO and Phase I Clinical Research Center Partners with Stanidobrovolets to Power Volunteer аnd Patient Recruitment for Clinical Research in Bulgaria

Convex CRO and Phase I Unit, a leading clinical research […]

Next-Generation SMART PFT Body Plethysmograph

Phase I Clinical Research Center Convex нow Equipped with Next-Generation […]

Diffusion Capacity for Carbon Monoxide (DLCO)

Diffusion Capacity for Carbon Monoxide (DLCO) Phase I clinical research […]

Clinical studies at Convex

Current clinical studies At Convex – dedicated clinical research site […]

Convex Phase I clinical research unit in Bulgaria expands

We are delighted to inform our clients and potential sponsors […]

COPD PATIENTS AND CLINICAL TRIALS IN BULGARIA – PHASE I CLINICAL RESEARCH SITE CONVEX

COPD stands for Chronic Obstructive Pulmonary Disease. It is a […]

CLINICAL TRIALS ON VACCINES

The development and testing of vaccines typically go through several […]

FOOD SUPPLEMENTS /NUTRACEUTICALS AND HOW THEY ARE BEING CLINICALLY PROVEN/ TESTED

Understanding Food Supplements: Benefits and Considerations Food supplements have gained […]

CLINICAL TRIALS INVOLVING ASTHMA PATIENTS IN BULGARIA

Asthma is a chronic respiratory condition that affects the airways […]

BULGARIA IS THE SPONSOR’S TOP CHOICE FOR CONDUCTING CLINICAL TRIALS

The choice of the most attractive country to conducting clinical […]

HOW TO SELECT PHASE I CLINICAL RESEARCH UNIT FOR YOUR CLINICAL TRIAL

Selecting a Phase I clinical research unit requires careful consideration […]

CONVEX PHASE I TEAM PARTICIPATED ON SWISS BIOTECH DAY

On 24 – 25 April 2023 Convex CRO and a […]

FIRST-IN-MAN STUDY (SINGLE ASCENDING/MULTIPLE ASCENDING DOSE STUDY SAD/MAD)

First-In-Man study (single ascending/multiple ascending dose study SAD/MAD) and how […]

Biomarkers in Phase 1 Clinical Trials

Biomarkers in Phase 1 Clinical Trials- Drug Development Insights Imagine […]